.png)
Embedded Clinical Trial Execution. Controlled. Scalable. Predictable.
MEET OUR PRINCIPAL INVESTIGATORS
Dedicated Investigators Advancing Clinical Research and Patient Care.
Our network of Principal Investigators includes board-certified physicians and experienced research leaders across multiple specialties, all committed to advancing medical science through high-quality clinical trials.
Each investigator is supported by RMP’s centralized operational, regulatory, and quality oversight frameworks, enabling efficient study start-up, strong enrollment performance, and reliable data integrity.
Through this integrated model, sponsors and CROs can engage experienced investigators while benefiting from consistent operational performance and scalable study execution across our growing research network.
Principal Investigator
Rogelio O. Bardinas, MD, FAAFP - Family Medicine
Dr. Rogelio O. Bardinas Rodriguez is a board-certified Family Medicine physician serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. With more than three decades of clinical and research experience, Dr. Bardinas has developed extensive expertise in primary care medicine, multidisciplinary clinical practice, and the execution of industry-sponsored clinical trials across multiple therapeutic areas.
Throughout his career, Dr. Bardinas has held several leadership positions in healthcare institutions, including serving as Medical Director for outpatient medical centers and leading multidisciplinary clinical teams responsible for delivering comprehensive patient care. His background also includes specialized training in orthopedic and trauma surgery, as well as experience managing complex musculoskeletal conditions and chronic disease populations.
Dr. Bardinas has extensive experience serving as both Principal Investigator and Sub-Investigator in Phase II–IV clinical trials sponsored by pharmaceutical companies and research organizations. His clinical research work spans a wide range of therapeutic areas including respiratory diseases, diabetes, cardiovascular conditions, infectious diseases, oncology screening, chronic pain management, and neurological disorders. This diverse research portfolio reflects his ability to manage complex study populations and support the development of innovative medical therapies.
Within the RMP clinical research network, Dr. Bardinas operates under a structured operational framework that integrates site-level clinical expertise with centralized regulatory oversight, standardized operating procedures, and sponsor-aligned governance. In this role, he is responsible for overseeing protocol implementation, patient safety monitoring, study participant evaluations, and ensuring strict adherence to regulatory and ethical standards throughout the clinical trial process.
Dr. Bardinas completed his medical education at the Instituto Superior de Ciencias Médicas in Havana, Cuba, and later completed residency training in Family Medicine in the United States. Earlier in his career, he also completed specialized training in orthopedic and trauma surgery, including advanced fellowships and surgical courses in orthopedic trauma and hand surgery. His international medical experience has allowed him to work in diverse healthcare systems and academic environments.
In addition to his clinical and research activities, Dr. Bardinas has contributed to academic medicine through multiple medical presentations and educational conferences covering topics such as cardiovascular disease, orthopedic trauma, obstetrics-related complications, and geriatric medicine. His commitment to medical education and clinical excellence has remained a consistent theme throughout his professional career.
Dr. Bardinas conducts his research activities in full compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP clinical research network, he supports sponsors and CRO partners in the successful execution of high-quality clinical trials while helping expand patient access to innovative therapies across multiple medical specialties.
Founder Principal Investigator
Gustavo G. Leon, MD - General Surgeon / Clinical Instructor
In Loving Memory of Dr. Gustavo G. Leon
Founder – Embedded SMO–MSO Model
Principal Investigator
Research Management Partners honors the life and legacy of Dr. Gustavo G. Leon, a distinguished physician, respected clinical researcher, and one of the visionary founders who helped establish the foundation of our Embedded SMO–MSO model.
Dr. Leon was a board-certified general surgeon with more than four decades of medical experience and over 15 years dedicated to clinical research. Throughout his career, he served as both Principal Investigator and Sub-Investigator in numerous industry-sponsored clinical trials spanning multiple therapeutic areas, including neurology, psychiatry, endocrinology, rheumatology, dermatology, renal disease, infectious disease, respiratory disorders, and gastrointestinal conditions.
His research contributions included participation in Phase I–III clinical trials, early-phase pharmacokinetic studies, complex therapeutic investigations, and long-term safety and efficacy programs. Dr. Leon collaborated with leading research organizations, academic institutions, and pharmaceutical sponsors, helping advance the development of innovative therapies for patients in need.
Known for his unwavering commitment to ethical research and patient care, Dr. Leon conducted his work with strict adherence to Good Clinical Practice (GCP), FDA regulations, and ICH guidelines. His leadership, professionalism, and dedication to scientific integrity helped shape the standards of quality and operational excellence that continue to guide the work of Research Management Partners today.
Beyond his clinical and research accomplishments, Dr. Leon played a foundational role in the creation and development of the RMP research network. His vision was centered on integrating clinical research directly into community-based healthcare settings, allowing patients to access cutting-edge therapies while maintaining the highest standards of safety, ethics, and scientific rigor.
Dr. Leon believed deeply in the power of collaboration between physicians, research organizations, and the broader medical community to accelerate medical innovation and improve patient outcomes. His legacy remains embedded in the mission and values of Research Management Partners.
Today, we honor his memory with gratitude and respect, recognizing the profound impact he had on our organization, our investigators, and the many patients whose lives were touched by his work.
May his soul rest in eternal peace.
​​
​
​
​
​
Principal Investigator
Jorge Borges, D.M.D - General Dentist, Prosthodontics Specialist
Dr. Jorge Borges is an accomplished General Dentist and Prosthodontics Specialist with more than 40 years of clinical experience in restorative, implant, aesthetic, and prosthetic dentistry. He has owned and operated multiple successful dental practices, providing comprehensive oral rehabilitation and advanced restorative care to diverse patient populations. Dr. Borges’ expertise includes implant restorations, fixed and removable prosthetics, cosmetic dentistry, and long-term management of complex oral health conditions.
Trained in both the United States and Cuba, he holds a D.M.D. from Nova Southeastern University and advanced specialty training in prosthetic dentistry. Fully bilingual in English and Spanish, Dr. Borges brings strong clinical judgment, exceptional technical skill, and decades of hands-on experience to every patient he serves. His background as a practice owner and prosthetic specialist reflects a deep commitment to high-quality, compassionate dental care.
Principal Investigator
​
Dr:Ernesto A. Zamora, MDGastroenterologist | Internal Medicine | Principal Investigator / Sub-Investigator
Ernesto A. Zamora is a board-certified gastroenterologist and internal medicine physician serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. He brings strong academic, clinical, and research experience in the fields of gastroenterology and hepatology, with extensive involvement in industry-sponsored clinical trials and academic medical research.
Dr. Zamora has participated as a Principal Investigator and Sub-Investigator in Phase II and Phase III clinical trials focused on gastrointestinal and hepatology conditions. His responsibilities include conducting protocol-driven eligibility assessments, performing diagnostic and screening endoscopic procedures, overseeing informed consent processes, monitoring patient safety, and ensuring accurate documentation of clinical data in accordance with sponsor and regulatory requirements.
Within the RMP research network, Dr. Zamora works under a structured operational framework that integrates clinical expertise with centralized regulatory oversight, standardized operating procedures, and sponsor-aligned governance. This model ensures consistent protocol adherence, data integrity, and efficient clinical trial execution across participating research sites.
In addition to his clinical research experience, Dr. Zamora is an accomplished academic contributor and has authored and co-authored several peer-reviewed publications in recognized medical journals. His research work includes studies related to gastrointestinal disorders, hepatology, infectious diseases affecting the liver, and complex gastrointestinal conditions. His academic background reflects a strong commitment to evidence-based medicine and the advancement of medical knowledge.
Dr. Zamora completed his gastroenterology fellowship training at the University of Texas Medical Branch (UTMB) following his internal medicine residency at SUNY Upstate University Hospital in New York. He earned his medical degree from the Universidad de Ciencias Médicas de Cienfuegos in Cuba and holds board certifications in Internal Medicine and Gastroenterology. His training and experience span multiple healthcare environments, including academic medical centers, community hospitals, and international clinical settings.
Dr. Zamora maintains strict adherence to international and U.S. regulatory standards governing clinical research, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) oversight. Through his work with the RMP clinical research network, he supports the successful execution of high-quality clinical trials while helping expand patient access to innovative therapies in the field of gastroenterology.
Fluent in both English and Spanish, Dr. Zamora is well positioned to serve diverse patient populations and contribute to the successful conduct of clinical research studies within the South Florida research community.
Principal Investigator
EDWARD GONZALEZ, DPM (Doctor of Podiatric Medicine), Wound CARE.
Dr. Edward Gonzalez is a Doctor of Podiatric Medicine serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. He brings extensive clinical and research experience in lower extremity care, with particular expertise in diabetic foot complications, chronic wounds, venous disease, and musculoskeletal disorders affecting the foot and ankle.
Dr. Gonzalez has participated as a Principal Investigator and Sub-Investigator in multiple industry-sponsored clinical trials across Phases I–III. His research work focuses on conditions affecting the lower extremities, including diabetic foot ulcers, plantar fasciitis, plantar fibromatosis, venous leg ulcers, and chronic wound healing disorders. Through these studies, he contributes to the evaluation of innovative therapies designed to improve wound healing outcomes and prevent complications associated with diabetes and vascular disease.
Within the RMP clinical research network, Dr. Gonzalez conducts studies under a centralized operational framework that integrates site-level clinical expertise with structured regulatory oversight, standardized operating procedures, and sponsor-aligned governance. This model supports consistent protocol adherence, accurate data collection, and high-quality clinical trial execution across participating research sites.
Dr. Gonzalez collaborates regularly with pharmaceutical sponsors, contract research organizations (CROs), and clinical research teams during all phases of study execution, including subject screening, informed consent procedures, safety monitoring, adverse event reporting, investigational product administration, and study follow-up. His experience includes working with numerous pharmaceutical companies and research organizations involved in the development of therapies for dermatologic, vascular, and wound-healing conditions.
In addition to his research activities, Dr. Gonzalez maintains an active clinical practice specializing in lower extremity care and advanced wound management. His clinical work provides direct access to patient populations commonly affected by diabetes-related foot complications, allowing him to contribute valuable real-world clinical insight to the design and execution of clinical trials.
Dr. Gonzalez completed his Doctor of Podiatric Medicine degree at the Ohio College of Podiatric Medicine and subsequently completed postgraduate training in podiatric medicine and surgery at both Westchester General Hospital in Miami and the William S. Middleton Memorial VA Hospital in Madison, Wisconsin. He holds active medical licensure in the State of Florida and maintains multiple certifications related to clinical research, including Good Clinical Practice (GCP), FDA-regulated research compliance, and investigational product management.
Through his participation in the RMP research network, Dr. Gonzalez supports the advancement of innovative therapies aimed at improving outcomes for patients suffering from chronic wounds, diabetic complications, and lower extremity disorders. His work contributes to expanding patient access to clinical trials while helping sponsors and CRO partners successfully conduct high-quality, well-controlled clinical studies.
Principal Investigator
Iliana Acosta MD - Internal Medicine
Ileana Acosta, MD – Principal Investigator
Dr. Ileana Acosta is a Florida-licensed physician serving as a Principal Investigator within the Research Management Partners (RMP) network, bringing over three decades of clinical experience and a proven track record in the execution of industry-sponsored clinical trials.
Operating within an embedded clinical research environment at Gables Medical Center in Miami, Dr. Acosta combines active patient care with structured research delivery—ensuring seamless integration of protocol requirements into real-world clinical practice. This model supports consistent patient access, high retention rates, and reliable study execution.
Dr. Acosta has contributed to multiple Phase II–IV clinical trials, including randomized, double-blind, placebo-controlled and multi-center studies across key therapeutic areas such as respiratory diseases, cardiovascular and metabolic disorders, infectious diseases (including COVID-19 prevention), and rare conditions. Her experience includes participation in advanced therapeutic protocols evaluating novel agents, biologics, and long-term safety and efficacy outcomes.
Through her role in clinical research, Dr. Acosta demonstrates strong operational discipline, adherence to ICH-GCP standards, and the ability to support high-quality data generation under demanding protocol conditions. Her involvement in complex studies requiring strict compliance, patient monitoring, and longitudinal follow-up reflects a high level of reliability from both an investigator and site performance perspective.
Dr. Acosta’s extensive clinical background—spanning internal medicine, OB/GYN, and primary care—enables her to manage diverse and often underserved patient populations, supporting enrollment efficiency and protocol adherence across a wide range of indications.
As part of the RMP embedded SMO model, Dr. Acosta operates under standardized SOPs, continuous on-site quality control, and centralized oversight—ensuring audit readiness, reduced protocol deviations, and consistent performance aligned with sponsor expectations.
She holds active medical licensure in Florida and Puerto Rico, is ECFMG certified, and maintains continuous medical education to support both her clinical and research responsibilities.
Principal Investigator
Juan A. Dorado, MD F A C P - Internal Medicine
Dr. Juan A. Dorado, MD, FACP, is a board-certified Internal Medicine physician with extensive experience in hospital medicine, hospice and palliative care, and academic teaching. He currently serves as an Academic Hospitalist at HCA Florida Kendall Hospital and provides specialized end-of-life care through multiple hospice organizations, including VITAS Healthcare, Catholic Health Services, and Bristol Hospice. In addition, he is a Clinical Assistant Professor of Internal Medicine at Nova Southeastern University and HCA Florida Kendall Hospital, where he contributes to medical education and mentorship.
Dr. Dorado earned his medical degree from Ross University School of Medicine and completed his Internal Medicine residency at Florida State University College of Medicine, where he gained experience presenting clinical research and leading educational seminars. He is a Diplomate of the American Board of Internal Medicine and a Fellow of the American College of Physicians, recognized for his excellence in clinical care and commitment to high professional standards. In 2025, he received the Physician Excellence Award from HCA Florida Kendall Hospital.
In addition to his clinical and academic roles, Dr. Dorado is active in health policy advocacy through the American College of Physicians and has authored multiple clinical presentations and case reports covering endocrinology, cardiology, geriatrics, infectious diseases, and rare conditions. Fluent in evidence-based medicine and dedicated to compassionate patient care, he brings strong leadership and clinical expertise to every healthcare setting he serves.
Principal Investigator
Melva R. Reve Urgelles, MD
Investigator / Sub-Investigator – Psychiatry
Research Management Partners (RMP) Network
Dr. Melva R. Reve Urgelles is a board-eligible psychiatrist participating as an Investigator and Sub-Investigator within the Research Management Partners (RMP) Site Management Organization network. She brings extensive clinical experience in psychiatric care across inpatient, outpatient, emergency, and telepsychiatry settings, supporting the evaluation and management of a wide range of mental health conditions.
Dr. Reve Urgelles has actively participated in industry-sponsored clinical trials in the field of psychiatry, contributing to Phase II and Phase III research studies focused on central nervous system (CNS) disorders. Her research experience includes protocol-driven psychiatric evaluations, patient eligibility assessments, informed consent procedures, and ongoing clinical monitoring of study participants throughout the trial lifecycle. She works closely with Principal Investigators, clinical research coordinators, and RMP’s centralized operations team to ensure accurate documentation, protocol adherence, and regulatory compliance during study execution.
Her clinical expertise includes the diagnosis and treatment of psychiatric disorders such as attention deficit hyperactivity disorder (ADHD), schizophrenia spectrum disorders, mood disorders, and other complex neuropsychiatric conditions. Through her work in both clinical practice and research environments, Dr. Reve Urgelles contributes to improving patient outcomes while supporting the development of innovative therapeutic options for individuals living with mental health disorders.
Dr. Reve Urgelles completed her medical degree at the University of Medical Sciences in Guantánamo, Cuba, and later completed her psychiatry residency training at Larkin Community Hospital in Miami, Florida. She is ECFMG certified and holds active medical licensure in Florida as well as regulatory certifications required for clinical research participation. She is fluent in both English and Spanish, allowing her to effectively serve diverse patient populations within the South Florida community.
Within the RMP network, Dr. Reve Urgelles conducts research under a centralized operational framework that integrates site-level clinical expertise with structured regulatory oversight, standardized operating procedures, and sponsor-aligned governance. Her work emphasizes patient safety, ethical conduct, and strict adherence to international and U.S. regulatory standards including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements.
Through her participation in the RMP clinical research network, Dr. Reve Urgelles helps expand patient access to clinical trials while supporting sponsors and CRO partners in the successful execution of high-quality clinical research studies.
Principal Investigator
Perpetua N. Ezeh-Aideyan MD - Board Certified Psychiatrist
Dr. Perpetua N. Ezeh-Aideyan is a board-certified Psychiatrist serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization (SMO) network. She brings extensive clinical and research experience in the evaluation and management of complex psychiatric conditions and has participated in numerous industry-sponsored clinical trials across multiple phases of drug development.
Dr. Ezeh-Aideyan has significant experience leading and supporting Phase I–IV clinical trials within the fields of psychiatry and central nervous system (CNS) disorders. Her research expertise includes mood disorders, major depressive disorder, bipolar disorder, schizophrenia spectrum disorders, anxiety disorders, and other neuropsychiatric conditions. Through her work as an investigator, she has contributed to the development and evaluation of novel therapeutic approaches designed to improve patient outcomes in psychiatric medicine.
Within the RMP network, Dr. Ezeh-Aideyan conducts clinical research under a structured operational framework that integrates site-level clinical expertise with centralized regulatory, operational, and quality oversight. This collaborative model ensures consistent adherence to study protocols, high standards of data quality, and efficient execution of clinical trials.
Her research activities emphasize patient safety, ethical conduct, and rigorous compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) oversight. Dr. Ezeh-Aideyan is committed to maintaining the highest standards of scientific integrity while providing compassionate, patient-centered care throughout the clinical research process.
Through her participation in the RMP clinical research network, Dr. Ezeh-Aideyan contributes to advancing psychiatric medicine by helping bring innovative investigational therapies to patients and supporting sponsors and CROs in the successful execution of high-quality clinical trials.
Principal Investigator
MARY LAUREN LOPEZ, DPM (Podiatric Physician)
Dr. Mary Lauren Lopez is a board-certified podiatric physician serving as a Sub-Investigator within the Research Management Partners (RMP) Site Management Organization network. She brings extensive clinical training and experience in the diagnosis and treatment of foot and ankle disorders, with particular expertise in both conservative and surgical management of lower extremity conditions.
Dr. Lopez completed comprehensive residency training in podiatric medicine and surgery at Larkin Community Hospital in South Miami, Florida. Her training included advanced exposure to forefoot and rearfoot pathology, diabetic foot management, wound care, and reconstructive surgical procedures. Throughout her residency and postgraduate training, she participated in multiple advanced surgical training programs and cadaver-based educational courses focused on foot and ankle surgery, arthroscopy, and complex lower extremity procedures.
Within the RMP clinical research network, Dr. Lopez supports Principal Investigators in the execution of industry-sponsored clinical trials related to lower extremity care, musculoskeletal disorders, and conditions affecting diabetic patient populations. Her responsibilities include assisting with patient evaluations, supporting protocol-required clinical assessments, contributing to the informed consent process, and participating in the monitoring and follow-up of study participants.
Dr. Lopez works under the centralized operational structure established by Research Management Partners, which integrates site-level clinical expertise with standardized operating procedures, regulatory oversight, and sponsor-aligned governance. This framework helps ensure consistent protocol implementation, high-quality data collection, and adherence to international clinical research standards.
In addition to her clinical practice, Dr. Lopez has prior academic research experience through her work with the University of Miami and Jackson Memorial Hospital, where she participated in NIH-funded epidemiological and public health research projects. Her work included patient recruitment, data analysis, and study coordination in large population-based research initiatives focused on Hispanic and Latino health outcomes.
Her research activities within the RMP network follow strict compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Dr. Lopez remains committed to maintaining the highest standards of patient safety, ethical conduct, and clinical data integrity while supporting the advancement of innovative therapies through clinical research.
Through her participation in the RMP research network, Dr. Lopez contributes to expanding patient access to clinical trials and supports sponsors and CRO partners in the successful execution of high-quality clinical studies in the field of podiatric medicine and lower extremity care.
Principal Investigator
Victor Manuel Pina, MD Board-Certified Gastroenterologist
& Principal Investigator
Dr. Victor Manuel Piña is a board-certified gastroenterologist and internal medicine specialist serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. With more than three decades of clinical experience, Dr. Piña has dedicated his career to the diagnosis and management of gastrointestinal and liver diseases while contributing to the advancement of clinical research in gastroenterology and hepatology.
Dr. Piña completed his fellowship training in Gastroenterology at the University of Miami / Jackson Memorial Hospital after completing his residency in Internal Medicine at Columbia University’s St. Luke’s Roosevelt Hospital Center in New York. His extensive training and professional background have allowed him to develop deep expertise in a wide range of gastrointestinal conditions, including inflammatory bowel disease, irritable bowel syndrome, gastroesophageal reflux disease (GERD), liver disorders, hepatitis, nonalcoholic fatty liver disease (NAFLD/NASH), and colorectal cancer screening.
Within the RMP clinical research network, Dr. Piña serves as a Principal Investigator supporting the execution of industry-sponsored clinical trials in gastroenterology and hepatology. His responsibilities include patient eligibility evaluation, oversight of endoscopic procedures, safety monitoring, protocol compliance, and collaboration with study teams to ensure high-quality data collection and adherence to regulatory requirements.
Dr. Piña has also contributed to multiple clinical research studies as a referral physician and Sub-Investigator in trials evaluating investigational therapies for conditions such as NASH, ulcerative colitis, irritable bowel syndrome, and other inflammatory gastrointestinal disorders. His participation in these studies demonstrates his commitment to advancing innovative treatments and improving outcomes for patients with complex digestive diseases.
In addition to his clinical and research activities, Dr. Piña maintains an active private gastroenterology practice and has held several leadership roles within hospital systems, including serving as Chairman of the Department of Gastroenterology at both Palmetto Hospital and Golden Glades Hospital. He also serves as a voluntary adjunct professor at the Herbert Wertheim College of Medicine at Florida International University, contributing to the education and mentorship of future physicians.
Dr. Piña conducts clinical research within the structured operational framework of Research Management Partners, which integrates site-level clinical expertise with centralized regulatory oversight, standardized operating procedures, and sponsor-aligned governance. This model supports consistent protocol implementation, high standards of patient safety, and reliable clinical data generation.
His research activities are performed in strict compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his work within the RMP network, Dr. Piña contributes to expanding patient access to clinical trials while supporting sponsors and CRO partners in the successful execution of high-quality clinical studies in gastroenterology.
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
Principal Investigator
Dayan Ojeda Damas, MD
Board Certified Internal Medicine & Nephrology Physician
Research Management Partners (RMP) Network
Dr. Dayan Ojeda Damas is a board-certified physician in Internal Medicine and Nephrology serving as a Sub-Investigator within the Research Management Partners (RMP) Site Management Organization (SMO) network. He brings extensive clinical experience in the diagnosis and management of complex medical conditions, with particular expertise in renal diseases, chronic kidney disease management, metabolic disorders, and acute care medicine.
Dr. Ojeda Damas has worked in diverse clinical environments including hospital settings, outpatient practices, and multidisciplinary care teams. His background in both Internal Medicine and Nephrology allows him to contribute valuable clinical insight during patient screening, eligibility assessments, safety monitoring, and protocol-specific medical evaluations required during clinical trials.
Within the RMP research network, Dr. Ojeda supports Principal Investigators in the execution of industry-sponsored clinical trials across multiple therapeutic areas. His role includes assisting with patient evaluation, monitoring clinical outcomes, reviewing laboratory data, and ensuring the appropriate medical oversight of study participants throughout the course of the trial. His expertise in complex chronic disease management is particularly valuable for studies involving patients with comorbid conditions commonly encountered in real-world clinical research populations.
Dr. Ojeda conducts his research activities under the centralized operational framework established by Research Management Partners. This model integrates site-level clinical expertise with structured regulatory oversight, standardized operating procedures, and centralized operational management. Through this structure, RMP ensures consistent study execution, protocol adherence, and high-quality clinical data generation across its research sites.
His clinical research activities are performed in strict compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Dr. Ojeda remains committed to maintaining the highest standards of patient safety, ethical conduct, and scientific integrity while supporting the advancement of innovative therapies through clinical research.
Through his participation in the RMP network, Dr. Ojeda contributes to expanding patient access to clinical trials and supports sponsors and CRO partners in the successful execution of high-quality, well-controlled clinical studies.
Principal Investigator
Robert F. Vassall, MD Principal Investigator | Board-Certified Psychiatrist
Dr. Robert F. Vassall is a board-certified psychiatrist serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. With more than 30 years of clinical, academic, and clinical research experience, Dr. Vassall has dedicated his career to advancing the understanding and treatment of complex psychiatric and neurological conditions through both patient care and clinical research.
Dr. Vassall has extensive experience leading industry-sponsored clinical trials as a Principal Investigator across multiple phases of drug development, including Phase II, Phase III, and Phase IV randomized, double-blind, placebo-controlled, and multicenter studies. His research work focuses on central nervous system (CNS) disorders, including Alzheimer’s disease, bipolar disorder, major depressive disorder, schizophrenia, attention-deficit/hyperactivity disorder (ADHD), and agitation associated with dementia.
Within the RMP clinical research network, Dr. Vassall plays a key role in the execution of sponsor-driven clinical trials by overseeing patient eligibility assessments, supervising psychiatric evaluations, monitoring study participants, and ensuring adherence to study protocols and regulatory requirements. His responsibilities include safety monitoring, adverse event assessment, and collaboration with multidisciplinary research teams to ensure the accurate collection of clinical data and high-quality study outcomes.
Dr. Vassall completed his medical education at Meharry Medical College in Nashville, Tennessee, where he also completed his residency training in psychiatry and served as Chief Resident in the Department of Psychiatry and Behavioral Sciences. His academic and clinical background provides a strong foundation for conducting complex psychiatric research and managing diverse patient populations participating in clinical trials.
Throughout his career, Dr. Vassall has contributed to numerous clinical studies evaluating novel pharmacological treatments for neuropsychiatric conditions. His experience includes studies investigating therapies for early Alzheimer’s disease, treatment-resistant depression, bipolar disorder maintenance therapy, schizophrenia, and cognitive impairment. His work supports the development of innovative treatments aimed at improving the quality of life for patients suffering from severe psychiatric and neurological disorders.
Dr. Vassall conducts his research activities under the centralized operational framework established by Research Management Partners, which integrates site-level clinical expertise with structured regulatory oversight, standardized operating procedures, and sponsor-aligned governance. This framework ensures consistent protocol compliance, high standards of patient safety, and reliable clinical data generation across research sites.
His research activities are conducted in strict compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP clinical research network, Dr. Vassall supports sponsors and CRO partners in the successful execution of high-quality clinical trials while expanding patient access to innovative therapies in psychiatric and neurological medicine.
Principal Investigator
FRANCISCO RICART, MD Board-certified Psychiatrist
Dr. Francisco Ricart is a board-certified psychiatrist serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. With extensive clinical and research experience in psychiatric and neurocognitive disorders, Dr. Ricart has contributed to numerous industry-sponsored clinical trials evaluating innovative therapies for complex mental health and neurological conditions.
Dr. Ricart has participated as both Principal Investigator and Sub-Investigator in multiple multicenter Phase II and Phase III clinical trials across several therapeutic areas. His research work focuses primarily on psychiatric and neurodegenerative disorders, including schizophrenia, major depressive disorder, Alzheimer’s disease, cognitive impairment, and other conditions associated with neurodegeneration and psychiatric dysfunction.
Throughout his clinical research career, Dr. Ricart has been actively involved in the full lifecycle of clinical trial execution. His responsibilities include patient recruitment and screening, psychiatric and cognitive assessments, protocol implementation, safety monitoring, adverse event evaluation, and oversight of regulatory compliance in accordance with international clinical research standards.
Dr. Ricart collaborates closely with research coordinators, sponsors, and contract research organizations to ensure accurate study documentation, high-quality data collection, and strict adherence to study protocols. His experience includes participation in randomized, double-blind, placebo-controlled clinical trials evaluating investigational therapies designed to improve outcomes for patients suffering from severe psychiatric and neurocognitive conditions.
In addition to his research activities, Dr. Ricart has an extensive background in clinical psychiatry, having practiced in both hospital-based and outpatient healthcare environments. His professional experience includes work with major medical institutions in New York and Miami, where he has provided psychiatric care for diverse patient populations and complex behavioral health conditions.
Dr. Ricart completed his medical education at the Universidad Autónoma de Santo Domingo and later completed his psychiatric residency training at Metropolitan Hospital Center in New York. He further advanced his clinical expertise through fellowship training in AIDS Psychiatry at the Mount Sinai School of Medicine, strengthening his experience in the psychiatric care of medically complex patients.
Within the RMP clinical research network, Dr. Ricart conducts research under a structured operational framework that integrates site-level clinical expertise with centralized regulatory oversight, standardized operating procedures, and sponsor-aligned governance. This model ensures consistent protocol implementation, high standards of patient safety, and reliable clinical data generation.
His research activities are conducted in strict compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP research network, Dr. Ricart contributes to advancing psychiatric medicine while supporting sponsors and CRO partners in the successful execution of high-quality clinical trials.
Principal Investigator
Isaac Levy, MD Hematology & Oncology
Principal Investigator – Hematology / Medical Oncology
Research Management Partners (RMP) Network
Dr. Isaac Levy is a board-certified medical oncologist and hematologist serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. With more than three decades of clinical experience in oncology and hematology, Dr. Levy has dedicated his career to the treatment of complex malignancies while actively contributing to the advancement of cancer research through participation in industry-sponsored clinical trials.
Dr. Levy completed fellowship training in oncology and hematology at the University of Miami School of Medicine and further specialized training in bone marrow transplantation at the Fred Hutchinson Cancer Center in Seattle. His medical training also includes residency in Internal Medicine at New York Medical College’s Metropolitan Hospital Center. This extensive academic background has provided him with a strong foundation in both clinical oncology practice and translational cancer research.
Throughout his career, Dr. Levy has maintained an active oncology practice in South Florida while participating as a Principal Investigator in numerous clinical trials evaluating innovative cancer therapies. His research experience includes Phase I, Phase II, and Phase III studies across a broad spectrum of malignancies, including breast cancer, lung cancer, prostate cancer, and hematologic malignancies such as multiple myeloma and myeloproliferative disorders.
Dr. Levy has collaborated with many of the world’s leading pharmaceutical sponsors and research organizations, contributing to the development and evaluation of targeted therapies, immunotherapies, and novel treatment combinations designed to improve outcomes for patients with advanced malignancies. His involvement in these trials includes patient eligibility evaluation, protocol implementation, safety monitoring, adverse event management, and oversight of regulatory compliance throughout the study lifecycle.
In addition to his work as a clinical investigator, Dr. Levy has served on multiple advisory boards for major pharmaceutical companies, participating in scientific discussions related to emerging oncology therapies, biomarker-driven treatment strategies, and advancements in precision medicine. His participation in these advisory panels reflects his recognition within the oncology community as an experienced clinician and research collaborator.
Within the RMP clinical research network, Dr. Levy operates under a centralized operational framework that integrates site-level clinical expertise with standardized operating procedures, regulatory oversight, and sponsor-aligned governance. This model ensures consistent protocol adherence, high standards of patient safety, and reliable clinical data generation across participating research sites.
Dr. Levy conducts his research activities in full compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP research network, he supports sponsors and CRO partners in the successful execution of high-quality oncology clinical trials while helping expand patient access to innovative cancer therapies.
Principal Investigator
LUIS S. VERAS, MD Internal Medicine Physician
Clinical Research Investigator
Principal Investigator – Internal Medicine / Geriatric Medicine
Research Management Partners (RMP) Network
Dr. Luis S. Veras is a board-certified Internal Medicine physician and clinical research investigator serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network. With extensive experience in both clinical medicine and clinical research, Dr. Veras has participated in numerous industry-sponsored clinical trials evaluating innovative therapies across multiple therapeutic areas.
Dr. Veras completed fellowship training in Geriatric Medicine at the University of Miami / Jackson Memorial Hospital following his residency training in Internal Medicine. His clinical background provides extensive experience in the management of adult and elderly patient populations, including complex chronic conditions commonly encountered in clinical research studies.
Throughout his research career, Dr. Veras has served as both Principal Investigator and Sub-Investigator in multicenter Phase II and Phase III clinical trials sponsored by pharmaceutical companies and research organizations. His research experience spans a broad range of therapeutic areas including Alzheimer’s disease, mild cognitive impairment, schizophrenia, major depressive disorder, infectious diseases, cardiovascular conditions, metabolic disorders, and diabetic kidney disease.
Dr. Veras has been actively involved in all aspects of clinical trial execution, including patient recruitment and eligibility screening, protocol implementation, clinical evaluations, safety monitoring, adverse event assessment, and oversight of regulatory compliance. He works closely with clinical research coordinators, study monitors, sponsors, and contract research organizations to ensure accurate documentation, protocol adherence, and high-quality clinical data generation.
In addition to his clinical research activities, Dr. Veras maintains an active clinical practice providing comprehensive internal medicine care for adult patients. His experience in managing diverse patient populations allows him to identify appropriate candidates for clinical trials and support strong patient retention throughout the study process.
Within the RMP clinical research network, Dr. Veras operates under a centralized operational framework that integrates site-level clinical expertise with standardized operating procedures, regulatory oversight, and sponsor-aligned governance. This model ensures consistent protocol compliance, high standards of patient safety, and reliable study execution across all participating research sites.
His research activities are conducted in full compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP network, Dr. Veras contributes to expanding patient access to clinical trials while supporting sponsors and CRO partners in the successful execution of high-quality clinical research studies.
Principal Investigator
Ricardo Presas MD, Internal Medicine
Dr. Ricardo Presas is a senior physician and Principal Investigator affiliated with the Research Management Partners (RMP) Site Management Organization network. With decades of clinical practice and leadership experience, Dr. Presas has developed extensive expertise across multiple areas of medicine, including internal medicine, emergency medicine, surgery, and clinical research.
Throughout his career, Dr. Presas has served in various leadership roles within healthcare and research organizations, including Medical Director and Principal Investigator for multiple industry-sponsored clinical trials. His research work includes participation in Phase II and Phase III studies evaluating investigational therapies across diverse therapeutic areas.
As a Principal Investigator, Dr. Presas has been responsible for overseeing the full execution of clinical trial protocols, including patient recruitment and eligibility evaluation, informed consent procedures, safety monitoring, and regulatory compliance. He works closely with sponsors, contract research organizations, and clinical research staff to ensure that studies are conducted in accordance with Good Clinical Practice (ICH-GCP) standards and regulatory requirements.
Dr. Presas has extensive experience collaborating with pharmaceutical sponsors and research organizations, contributing to high-quality clinical data generation while maintaining strict oversight of patient safety and study integrity. His responsibilities also include supervising research staff, supporting monitoring visits and regulatory inspections, and ensuring accurate source documentation in alignment with ALCOA+ data integrity principles.
In addition to his clinical research activities, Dr. Presas maintains a long-standing clinical practice providing comprehensive medical care to adult patients in the South Florida community. His broad medical background and experience in multidisciplinary care settings enable him to support the recruitment and management of diverse patient populations participating in clinical trials.
Within the RMP research network, Dr. Presas operates under a centralized operational framework that integrates site-level clinical expertise with standardized operating procedures, regulatory oversight, and sponsor-aligned governance. This model supports consistent protocol implementation, strong operational control, and high standards of patient safety across all participating research sites.
Dr. Presas conducts clinical research activities in full compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP network, he supports sponsors and CRO partners in the successful execution of high-quality clinical trials while helping expand patient access to innovative therapies.
Rafael Crespo, MD
Principal Investigator – Internal Medicine
Dr. Rafael Crespo is a senior physician specializing in Internal Medicine with more than four decades of clinical experience in patient care and hospital-based medicine. He has extensive experience managing complex adult medical conditions including cardiovascular disease, kidney disorders, metabolic diseases, and acute medical conditions.
He obtained his medical degree from Universidad Católica Nordestana School of Medicine and completed postgraduate medical training including residency at Raritan Bay Medical Center in New Jersey.
Dr. Crespo is currently licensed to practice medicine in the state of Florida and maintains hospital affiliations with major healthcare institutions including Jackson Memorial Hospital and HCA Florida Mercy Hospital in Miami.
Throughout his career, Dr. Crespo has developed extensive experience in adult internal medicine, chronic disease management, and hospital-based patient care, including treatment of hypertension, cardiovascular disease, metabolic disorders, and renal conditions.
With decades of clinical practice and experience working within multidisciplinary healthcare systems, Dr. Crespo brings valuable expertise to industry-sponsored clinical research programs, contributing to patient safety oversight, protocol compliance, and accurate clinical data collection.
J.W. Rodriguez, MD
Principal Investigator | Obstetrics & Gynecology
Dr. J.W. Rodriguez is a board-certified Obstetrician-Gynecologist with over four decades of clinical experience and a well-established background in women’s health and clinical research. As a Principal Investigator within the Research Management Partners (RMP) network, he actively supports the execution of clinical trials focused on gynecologic conditions and women’s health.
Dr. Rodriguez has extensive experience in the management and treatment of complex gynecological conditions, including uterine fibroids, endometriosis, chronic pelvic pain, and gynecologic oncology-related conditions. His long-standing clinical practice, combined with his affiliation with major healthcare institutions, provides a strong foundation for high-quality patient recruitment and retention in clinical trials.
In the research setting, Dr. Rodriguez has participated as a Principal Investigator in multiple clinical studies within gynecology, contributing to the evaluation of novel therapies and treatment approaches for conditions such as endometriosis, fibroid tumors, and interstitial cystitis.
He brings a deep understanding of protocol execution, patient safety, and regulatory compliance, ensuring adherence to ICH-GCP standards and sponsor requirements. His ability to integrate clinical expertise with research operations allows for efficient study conduct and consistent data quality across trials.
With over 40 years of medical experience, Dr. Rodriguez offers a high level of clinical judgment, patient trust, and operational stability—key factors in achieving reliable enrollment and successful study outcomes within multi-site clinical research environments.
Dr. Odalys Frontela, MD – Internal Medicine
Dr. Odalys Frontela is a board-certified Internal Medicine physician with extensive clinical and research experience across inpatient and outpatient settings. With decades of medical practice, she brings a strong foundation in chronic disease management, community-based care, and hospital medicine.
Her clinical expertise includes management of complex patient populations, cardiovascular risk conditions, metabolic disorders, and geriatric care. Dr. Frontela has also played a significant role in medical education, training internal medicine residents and medical students while maintaining active clinical practice.
In clinical research, Dr. Frontela has served as both Principal Investigator and Sub-Investigator in multiple Phase II–IV trials across diverse therapeutic areas including endocrinology, hepatology, rheumatology, cardiology, infectious diseases, oncology, pulmonology, neurology, psychiatry, gastroenterology, and dermatology. Her experience includes participation in multicenter studies sponsored by major pharmaceutical companies such as AstraZeneca, Sanofi, Pfizer, Takeda, and AbbVie.
She is affiliated with leading healthcare institutions in South Florida, including Hialeah Hospital and Palmetto General Hospital, and maintains active involvement in professional organizations such as the American College of Physicians (ACP) and the American Medical Association (AMA).
Dr. Frontela’s combination of clinical depth, research experience, and patient-centered approach positions her as a reliable and effective investigator within the RMP network, supporting high-quality trial execution and consistent patient engagement.
Juan C. Sarol, MD
Gastroenterology | Principal Investigator
Dr. Juan C. Sarol is a board-certified Gastroenterologist and Internal Medicine physician with over 40 years of clinical experience. Based in Hialeah, Florida, Dr. Sarol has established a long-standing medical practice serving a diverse patient population with a wide range of gastrointestinal conditions.
Throughout his career, Dr. Sarol has combined clinical excellence with active participation in clinical research. He brings extensive experience as a Principal Investigator and Sub-Investigator across multiple industry-sponsored clinical trials, particularly in gastrointestinal and inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease.
Dr. Sarol’s clinical practice provides direct access to a robust patient population, supporting efficient identification and recruitment of eligible participants. His affiliation with multiple hospitals and his integration within the local healthcare network further enhance his ability to support complex study protocols and ensure continuity of care.
Fluent in both English and Spanish, Dr. Sarol is well-positioned to engage diverse patient populations and contribute to high-quality clinical trial execution. His experience, patient access, and commitment to research excellence make him a valuable addition to the Research Management Partners (RMP) network.
Alejandro Espaillat, MD
Ophthalmology & Aesthetic Medicine | Principal Investigator
Dr. Alejandro Espaillat is a Florida-licensed Eye Physician and Surgeon with advanced training through Harvard University and Brown University affiliated hospitals. He is a Diplomate in Aesthetic Medicine and is board-certified by the American Academy of Aesthetic Medicine.
Dr. Espaillat has extensive experience in both ophthalmic and aesthetic procedures, having performed thousands of successful surgical and minimally invasive treatments. His expertise includes aesthetic facial neurotoxin injections, dermal fillers, laser skin rejuvenation, advanced chemical peels, and regenerative therapies such as platelet-rich plasma (PRP) and stem cell-based treatments.
He is an active member in good standing of multiple professional organizations, including the American Academy of Aesthetic Medicine, American Academy of Cosmetic Surgery, American Society for Laser Medicine and Surgery, American Academy of Ophthalmology, and the American Society of Cataract and Refractive Surgery.
In addition to his clinical work, Dr. Espaillat has participated in clinical research and contributed as a co-author to multiple published medical reports. His combined surgical expertise and research experience support the execution of specialized clinical trials in ophthalmology, aesthetic medicine, and device-based studies.
Denise Maria Negron, DPM – Podiatry
Dr. Denise Maria Negron is a podiatric physician with more than three decades of clinical experience and an established practice in Hialeah, Florida. As part of the Research Management Partners (RMP) network, she contributes to the execution of clinical research studies within an embedded site model, supporting consistent and high-quality trial delivery.
Dr. Negron brings extensive experience managing diverse patient populations, including individuals with chronic conditions such as diabetes, peripheral vascular disease, and complex wound care needs—key populations for clinical research in podiatry and related therapeutic areas. Her clinical expertise enables accurate patient identification, protocol adherence, and effective study execution in real-world practice settings.
Within the RMP framework, Dr. Negron participates in clinical research activities as a Principal Investigator or Sub-Investigator, supported by centralized regulatory oversight, standardized SOPs, and continuous quality control. This structure allows her site to operate under consistent research standards while maintaining continuity of care for enrolled patients.
Her areas of clinical focus include diabetic foot management, wound care, plantar fasciitis, nail disorders, and other foot and ankle conditions, providing access to relevant patient populations for industry-sponsored trials.
Dr. Negron is committed to maintaining protocol compliance, data integrity, and patient safety, contributing to reliable study outcomes and audit-ready performance within the RMP network.
Damian Casadesus, MD – Internal Medicine | Principal Investigator
Dr. Damian Casadesus is a board-certified Internal Medicine physician and experienced Principal Investigator with a strong background in both clinical care and translational research. He currently serves as a Principal Investigator at Gables Med Research and Life Arc Research in Miami, Florida, while maintaining an active clinical role at Jackson Memorial Hospital.
Dr. Casadesus holds a PhD in Medical Sciences and has extensive research training in molecular biology, with prior academic and research appointments in the United States, Japan, and Cuba. His multidisciplinary background combines clinical medicine, surgical training, and advanced research methodology, enabling him to effectively lead complex clinical trials across multiple therapeutic areas.
As a Principal Investigator, Dr. Casadesus has led and participated in Phase I–III clinical trials, including studies in COPD, Alzheimer’s disease, oncology screening, vaccines, autoimmune disorders, and alcohol use disorder. His experience spans randomized, double-blind, placebo-controlled trials, as well as observational and biospecimen collection studies, supporting both therapeutic development and diagnostic innovation.
He also brings extensive experience as a Sub-Investigator across additional indications such as asthma, osteoarthritis, rheumatoid arthritis, migraine, and neurodegenerative disorders, demonstrating broad therapeutic versatility and adaptability in clinical research execution.
Dr. Casadesus is GCP-certified and trained in multiple clinical rating scales commonly used in CNS trials, including ADAS-Cog, MMSE, MOCA, CDR, and others, supporting high-quality data collection and endpoint reliability in complex protocols.
Fluent in English, Spanish, Italian, and Japanese, he is well-positioned to work with diverse patient populations and support inclusive recruitment strategies. His approach to research emphasizes protocol compliance, patient safety, and data integrity, contributing to consistent, audit-ready performance within the RMP network.
Noel Garcia Acosta, MD – Internal Medicine | Principal Investigator / Sub-Investigator
Dr. Noel Garcia Acosta is an Internal Medicine physician actively involved in clinical research execution across multiple therapeutic areas, contributing to study delivery within the Research Management Partners (RMP) network. He currently practices in Miami, Florida, and serves as a hospitalist at Jackson Memorial Hospital, providing direct access to diverse and high-volume patient populations.
Dr. Garcia Acosta completed his Internal Medicine residency at Mountain View Hospital in Las Vegas and has successfully completed all USMLE examinations. His clinical background supports strong patient management, protocol adherence, and accurate identification of eligible study participants in real-world clinical settings.
He has participated as Principal Investigator and Sub-Investigator in Phase I–III clinical trials, including studies in COPD, migraine, Sjögren’s syndrome, vaccine development, CNS-related biomarkers, and oncology screening programs. His experience includes randomized, double-blind, placebo-controlled trials as well as multicenter and multinational studies, demonstrating capability in complex protocol execution.
In addition to his clinical trial work, Dr. Garcia Acosta has contributed to academic research, including a published study in ophthalmology and participation in public health research initiatives.
Fluent in English and Spanish, he is well-positioned to support recruitment and retention across diverse patient populations. Within the RMP embedded SMO model, Dr. Garcia Acosta operates under standardized SOPs, centralized oversight, and continuous quality control, ensuring consistent, compliant, and audit-ready study execution.
Kenia Rodes, MD
Principal Investigator | Board-Certified Internal Medicine
Dr. Kenia Rodes is a Board-Certified Internal Medicine physician and experienced Principal Investigator with extensive leadership in Phase I–IV clinical trials across multiple therapeutic areas, including dermatology, metabolic disorders, respiratory diseases, infectious diseases, cardiovascular conditions, immunology, and psychiatry.
She has a proven track record managing high-volume clinical research portfolios, with deep expertise in protocol oversight, regulatory compliance (ICH-GCP, FDA, IRB), patient safety monitoring, and data integrity under ALCOA++ standards. Dr. Rodes has consistently collaborated with global sponsors and CROs, maintaining strong enrollment performance, audit readiness, and high-quality study execution.
Her experience includes leading and supporting numerous Phase II–IV studies in indications such as psoriasis, atopic dermatitis, obesity, diabetes, asthma, chronic cough, major depressive disorder, and vaccine trials, demonstrating broad therapeutic versatility and operational consistency.
Dr. Rodes combines strong clinical acumen with research leadership, supported by a multidisciplinary background that includes prior experience as a Registered Nurse and hospitalist physician. This foundation enhances her ability to manage complex patient populations and ensure protocol adherence and patient retention.
Bilingual in English and Spanish, she plays a key role in engaging diverse patient populations and supporting inclusive recruitment strategies.
Dr. Lorenzo Riera, MD
Principal Investigator / Sub-Investigator – Family Medicine
Dr. Lorenzo Riera is a highly experienced Family Medicine physician with over five decades of clinical practice in South Florida, providing comprehensive care across diverse patient populations. His extensive clinical background supports effective patient identification, screening, and retention strategies within clinical research protocols.
Dr. Riera is licensed in the State of Florida (ACN797, active through January 2028) and maintains an active National Provider Identifier (NPI). He has practiced across multiple healthcare settings, contributing to broad therapeutic exposure and consistent patient management in real-world clinical environments.
Through his collaboration with Research Management Partners (RMP), Dr. Riera supports the execution of clinical trials within an embedded care model, ensuring integration of research activities into routine clinical practice. His involvement contributes to reliable enrollment, protocol adherence, and continuity of patient care throughout study participation.
Dr. Riera’s practice enables access to a stable and diverse patient base, supporting feasibility assessments and enrollment performance across multiple therapeutic areas, including primary care-driven indications, metabolic conditions, and observational studies.
Dr. Guari Mascaro, MD
Principal Investigator / Sub-Investigator – Family Medicine
Dr. Guari Mascaro is a licensed Family Medicine physician based in Miami, Florida, with over five decades of clinical experience providing care to diverse patient populations across multiple practice locations. Her extensive background in primary care supports effective patient identification, screening, and long-term follow-up within clinical research protocols.
Dr. Mascaro holds an active Florida Medical License (ME0081213) and maintains a National Provider Identifier (NPI: 1265485213). Her clinical practice is characterized by continuity of care and access to a broad patient base, enabling consistent enrollment and retention across a range of therapeutic areas.
Through her collaboration with Research Management Partners (RMP), Dr. Mascaro contributes to the execution of clinical trials within an embedded research model, integrating study procedures into routine clinical workflows while maintaining high standards of patient care and protocol compliance.
Her participation supports feasibility assessments, enrollment performance, and reliable data generation, particularly in studies aligned with primary care, metabolic conditions, and observational research.
Silvia de Armas, MD, RCPSC, LMCC
Principal Investigator | Psychiatry
Board-certified psychiatrist with over 11 years of clinical experience in Canada, bringing extensive expertise in both inpatient and outpatient psychiatric care across diverse patient populations. Dr. de Armas has managed a wide range of moderate to severe psychiatric conditions, including mood disorders, schizophrenia, anxiety disorders, ADHD, and geriatric and perinatal psychiatry.
She has held leadership roles as Chief Psychiatrist of Outpatient Services at Hôpital Général de Saint-Jérôme, where she directed multidisciplinary teams and oversaw clinical operations, ensuring high-quality, structured patient care delivery.
Dr. de Armas combines strong clinical execution with academic involvement, having supervised and trained medical students through Université de Montréal, reinforcing adherence to standardized clinical practices and evaluation frameworks.
Her background also includes early specialization in pediatrics and pediatric oncology, providing a solid foundation for patient-centric care and complex case management.
Fully licensed in Canada (CMQ, LMCC) and certified by the Royal College of Physicians and Surgeons of Canada (RCPSC), Dr. de Armas operates under rigorous clinical and regulatory standards, aligning with ICH-GCP principles and high-quality data generation expectations
